Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Partial Epilepsies Clinical Trial

Official title:
An Open-label Extension Trial to Determine Safety and Efficacy of Long-term Oral SPM 927 in Patients With Partial Seizures

Status Completed

Clinical Trial Summary

The purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy

n/a

See also
Status	Clinical Trial	Phase
Completed	`NCT01235403` - Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure	Phase 4
Completed	`NCT00955357` - Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures	Phase 4
Completed	`NCT00552305` - To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures	Phase 2
Completed	`NCT00655486` - Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures	Phase 3
Completed	`NCT00655551` - Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures	Phase 3